Cargando…
Low bone mineralization in phenylketonuria may be due to undiagnosed metabolic acidosis()
BACKGROUND: Dietary intervention is to date the mainstay treatment to prevent toxic phenylalanine (Phe) accumulation in PKU patients. Despite success preventing central nervous system damage, there is increasing evidence of possible other unfavorable outcomes affecting other systems, e.g. kidney and...
Autores principales: | Rovelli, Valentina, Ercoli, Vittoria, Dionigi, Alice Re, Paci, Sabrina, Salvatici, Elisabetta, Zuvadelli, Juri, Banderali, Giuseppe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10432846/ https://www.ncbi.nlm.nih.gov/pubmed/37600232 http://dx.doi.org/10.1016/j.ymgmr.2023.100998 |
Ejemplares similares
-
Telehealth and COVID-19: Empowering Standards of Management for Patients Affected by Phenylketonuria and Hyperphenylalaninemia
por: Rovelli, Valentina, et al.
Publicado: (2021) -
Breastfeeding in Phenylketonuria: Changing Modalities, Changing Perspectives
por: Zuvadelli, Juri, et al.
Publicado: (2022) -
PKU and COVID19: How the pandemic changed metabolic control
por: Rovelli, Valentina, et al.
Publicado: (2021) -
L-alanine supplementation in Pompe disease (IOPD): a potential therapeutic implementation for patients on ERT? A case report
por: Rovelli, Valentina, et al.
Publicado: (2022) -
Hyperphenylalaninemias genotyping: Results of over 60 years of history in Lombardy, Italy
por: Rovelli, Valentina, et al.
Publicado: (2022)